Universal pan-sarbecovirus vaccine (GreenLight Biosciences)

N/A

Report date: 2025/12/18 17:46:44

Base Information

Drug NameUniversal pan-sarbecovirus vaccine (GreenLight Biosciences)

Drug Alias NameCovid-19 pan sarbecovirus vaccine (Greenlight Biosciences)Next generation coronavirus vaccine (Greenlight Biosciences)mRNA based vaccine (Greenlight Biosciences)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionAngiotensin-converting enzyme 2 modulators

TargetsAngiotensin-converting enzyme 2

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGreenlight Biosciences

China Registration ClassN/A

Develop Information

Active CompaniesGreenlight Biosciences

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A